Weimai Qingtong Medical Technology Completes Tens of Millions Yuan B+ Round

Weimai Qingtong Medical Technology Completes Tens of Millions Yuan B+ Round

Weimai Qingtong Medical Technology (WEMT), a medical device company based in Wuxi, has completed a B+ financing round worth tens of millions of yuan. The round was led by Wuxi Capital Group Co., Ltd. and Jinsheng Capital, with WinX Capital serving as the exclusive financial advisor. The funds will be used to strengthen sales, expand market channels, build the brand, and support ongoing product research and development.

Investor Background
Wuxi Capital Group Co., Ltd., a state-owned venture capital institution, focuses on strategic emerging industries such as biomedicine. The group adheres to the investment philosophy of “investing in the future, talent, and innovation,” targeting industries with high growth potential and technical requirements. Jinsheng Capital, another lead investor, focuses on core industries like healthcare, emphasizing unique competitive advantages and innovation.

Company Profile
As a talent introducing enterprise by the Wuxi government, WEMT’s technical team has established the “Energy Medicine Engineering Research Center” in collaboration with Tsinghua University Wuxi Applied Technology Research Institute. The company has also actively participated in Wuxi’s technological innovation and industrial development, becoming a key driver in advancing local industries to a higher level.

Product and Technology
WEMT focuses on the medical device industry, adopting a “medical-engineering integration” approach with high-performance radiofrequency energy systems as its core technology. The company has a diverse product pipeline targeting both serious and consumer medical sectors. Its flagship product, YOUMAGIC High-Energy Monopolar Radiofrequency, features innovative technologies such as 100-millisecond flash pulse, dynamic pulse, and multi-cooling, offering consumers a more comfortable, safe, and effective choice. Multiple WEMT products, including YOUMAGIC, have obtained NMPA Class III medical device approval, with commercialization efforts accelerating.

Future Plans
Jinsheng Capital will integrate resources to support WEMT’s innovation and commercialization, contributing to the upgrade of the medical device industry. WEMT’s management stated that with the support of this round of financing, the company will expedite market expansion and continue to advance product development and technological innovation, aiming to meet real market demands and provide high-quality products. The company will also deepen cooperation with capital and local industries to build a modern industrial system.-Fineline Info & Tech

Leave a Reply

Your email address will not be published. Required fields are marked *

Insight, China's Pharmaceutical Industry